Skip to content

Organon OGN Other Working Capital

Other Working Capital at other companies

Amgen logo
AmgenAMGN
$67M+34.0%
Biogen logo
BiogenBIIB
$89M+66.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$1.49M-13.2%
Viatris logo
ViatrisVTRS
$22.9M-87.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$7.63M+115%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's other working capital?
Organon (OGN) reported other working capital of -$8M in Q1 2026.
How has Organon's other working capital changed year-over-year?
Organon's other working capital increased by 80.0% year-over-year, from -$40M to -$8M.
What is the long-term trend for Organon's other working capital?
Over 2 years (2021 to 2025), Organon's other working capital has grown at a 59.0% compound annual growth rate (CAGR), from -$55M to -$139M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.